Determining the extent to which delayed-enhancement images reflect the partition-coefficient of Gd-DTPA in canine studies of reperfused and unreperfused myocardial infarction

Magnetic Resonance in Medicine

Volumn 52, Issue 5, 2004, Pages 1069-1079

  Thornhill, Rebecca E ^a,c,e   Prato, Frank S ^a,c   Wisenberg, Gerald ^b,c   Moran, Gerald R ^d   Sykes, Jane ^a  

^a LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

^e ST JOSEPH S HEALTH CENTRE   (Canada)

Author keywords

Cardiac MRI; Gd DTPA; MRI; Myocardial infarction; Myocardial viability

Indexed keywords

ANIMALS; CARDIOLOGY; CELL DEATH; GADOLINIUM COMPOUNDS; MAGNETIC RESONANCE IMAGING;

CARDIAC MRI; DELAY TIME; GD-DTPA; MYOCARDIAL INFARCTION; MYOCARDIAL VIABILITY; PARTITION COEFFICIENT; POST INJECTION;

IMAGE ENHANCEMENT;

GADOLINIUM PENTETATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BOLUS INJECTION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DOG; HEART INFARCTION; IMAGE ENHANCEMENT; INTERMETHOD COMPARISON; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTITION COEFFICIENT; REPERFUSION INJURY;

EID: 7544247897     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.20236     Document Type: Article

References (38)

1. Bax JJ, van Eck-Smit BLF, van der Wall EE. Assessment of tissue viability: clinical demand and problems. Eur Heart J 1998;19:847-858.
2. Weber KT, Brilla CG. Factors associated with reactive and reparative flbrosis of the myocardium. Basic Res Cardiol 1992;87(Suppl 1):291-301.
3. Willenheimer R. Left ventricular remodelling and dysfunction: can the process be prevented? Int J Cardiol 2000;72:143-150.
4. Weinmann HJ, Laniado M, Mutzel W. Pharmacokinetics of Gd-DTPA/dimeglumine after intravenous injection into healthy volunteers. Physiol Chem Phys Med NMR 1984;16:167-172.
5. Prato FS, Wisenberg G, Marshall TP, Uksik P, Zabel P. Comparison of the biodistribution of gadolinium-153 DTPA and technetium-99m DTPA in rats. J Nucl Med 1988;29:1683-1687.
6. Pereira RS, Prato FS, Sykes J, Wisenberg G. Assessment of myocardial viability using MRI during a constant infusion of Gd-DTPA: further studies at early and late periods of reperfusion. Magn Reson Med 1999;42:60-68.
7. Flacke SJ, Fischer SE, Lorenz CH. Measurement of the gadopentetate dimeglumine partition coefficient in human myocardium in vivo: normal distribution and elevation in acute and chronic infarction. Radiology 2001;218:703-710.
8. Diesbourg LD, Prato FS, Wisenberg G, Drost DJ, Marshall TP, Carroll E, O'Neill B. Quantification of myocardial blood flow and extracellular volumes using a bolus injection of Gd-DTPA: kinetic modeling in canine ischemic disease. Magn Reson Med 1992;23:239-253.
9. Pereira RS, Prato FS, Lekx KS, Sykes J, Wisenberg G. Contrast-enhanced MRI for the assessment of myocardial viability after permanent coronary artery occlusion. Magn Reson Med 2000;44:309-316.
10. Pereira RS, Wisenberg G, Prato FS, Yvorchuk K. Clinical assessment of myocardial viability using MRI during a constant infusion of Gd-DTPA. MAGMA 2000;11:104-113.
11. Judd RM, Lugo-Olivieri CH, Aral M, Kondo T, Croisille P, Lima JAC, Mohan BS, Becker LC, Zerhouni EA. Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation 1995;92:1902-1910.
12. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen E-L, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100:1992-2002.
13. Fieno DS, Kim RJ, Chen E-L, Lomasney JW, Klocke FJ, Judd RM. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol 2000;36:1985-1991.
14. Kim RJ, Wu E, Rafael A, Chen E-L, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-1453.
15. Choi KM, Kim RJ, Gubernikoff G, Vargas JD, Parker M, Judd RM. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation 2001;104:1101-1107.
16. Gerber BL, Garot J, Bluemke DA, Wu KC, Lima JAC. Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation 2002;106:1083-1089.
17. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 2001;357:21-28.
18. Klein C, Nekolla SG, Bengel FM, Momose M, Sammer A, Haas F, Schnackenburg B, Delius W, Mudra H, Wolfram D, Schwaiger M. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 2002;105:162-167.
19. Mahrholdt H, Wagner A, Holly TA, Elliott MD, Bonow RO, Kim RJ, Judd RM. Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging. Circulation 2002;106:2322-2327.
20. Simonetti OP, Kim RJ, Fieno DS, Hillenbrand HB, Wu E, Bundy JM, Finn JP, Judd RM. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001;218:215-223.
21. Grebe O, Paetsch I, Kestler HA, Herkommer B, Schnackenburg B, Hornbach V, Fleck E, Nagel E. Optimal acquisition parameters for contrast enhanced magnetic resonance imaging after chronic myocardial infarction. J Cardiovasc Magn Reson 2003;5:575-587.
22. Foo TKF, Bernstein MA, Aisen AA, Hernandez RJ, Collick BD, Bernstein T. Improved ejection fraction and flow velocity estimates with use of view sharing and uniform repetition time excitation with fast cardiac techniques. Radiology 1995;195:471-478.
23. Tong CY, Prato FS, Wisenberg G, Lee T-Y, Carroll E, Sandler D, Wills J. Techniques for the measurement of the local myocardial extraction efficiency for inert diffusible contrast agents such as gadopentate dimeglumine. Magn Reson Med 1993;30:332-336.
24. Robb RA, Hanson DP. The ANALYZE software system for visualization and analysis in surgery simulation. In: Lavalle S, Taylor R, Burdea G, Mosges R, editors. Computer integrated surgery. Cambridge, MA: MIT Press; 1995.
25. Lin LI. A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989;45:255-268.
26. Fishbein MC, Meerbaum S, Rit J, Lando U, Kanmatsuse K, Mercier JC, Corday E, Ganz W. Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J 1981;101:593-600.
27. Langmack KA, Barber RW. A general method for the measurement of radionuclide mixtures. Phys Med Biol 1992;37:469-474.
28. Pereira RS, Prato FS, Wisenberg G, Sykes J. The determination of myocardial viability using Gd-DTPA in a canine model of acute myocardial ischemia and reperfusion. Magn Reson Med 1996;36:684-693.
29. Zar JH. Biostatistical analysis. Englewood Cliffs, NJ: Prentice Hall; 1998. 929 p.
30. Moran GR, Thornhill RE, Sykes J, Prato FS. Myocardial viability imaging using Gd-DTPA: physiological modeling of infarcted myocardium, and impact on injection strategy and imaging time. Magn Reson Med 2002;48:791-800.
31. Sun Y, Weber KT. Infarct scar: a dynamic tissue. Cardiovasc Res 2000; 46:250-256.
32. Thornhill RE, Prato FS, Wisenberg G. The assessment of myocardial viability: a review of current diagnostic imaging approaches. J Cardiovasc Magn Reson 2002;4:381-410.
33. Oshinski JN, Yang Z, Jones JR, Mata JF, French BA. Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging. Circulation 2001;104:2838-2842.
34. Flacke S, Allen JS, Chia JM, Wible JH, Periasamy MP, Adams MD, Adzamli IK, Lorenz CH. Characterization of viable and nonviable myocardium at MR imaging: comparison of gadolinium-based extracellular and blood pool contrast materials versus manganese-based contrast materials in a rat myocardial infarction model. Radiology 2003;226: 731-738.
35. Judd RM, Kim RJ. Imaging time after Gd-DTPA injection is critical in using delayed enhancement to determine infarct size accurately with magnetic resonance imaging [Letter]. Circulation 2002;106:e6.
36. Kellman P, Arai AE, McVeigh ER, Aletras AH. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med 2002;47:372-383.
37. Kraitchman DL, Heldman AW, Atalar E, Amado LC, Martin BJ, Pittenger MF, Hare JM, Bulte JWM. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 2003; 107:2290-2293.
38. Perin EC, Silva GV, Sarmento-Leite R, Sousa ALS, Howell M, Muthupillai R, Lambert B, Vaughn WK, Flamm SD. Assessing myocardial viability and infarct transmurality with left ventricular electromechanical mapping in patients with stable coronary artery disease: validation by delayed-enhancement magnetic resonance imaging. Circulation 2002;106:957-961.